Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Jan Kubis
The Tyrosine Kinase Inhibitor Dasatinib Reduces the Growth of Intracellular Mycobacterium Tuberculosis Despite Impairing T-Cell Function
European Journal of Immunology
Allergy
Immunology
Related publications
A Spleen Tyrosine Kinase Inhibitor Reduces the Severity of Established Glomerulonephritis
Journal of the American Society of Nephrology : JASN
Medicine
Nephrology
The Tyrosine Kinase Inhibitor Dasatinib Induces a Marked Adipogenic Differentiation of Human Multipotent Mesenchymal Stromal Cells
PLoS ONE
Multidisciplinary
Modelling Ponatinib Resistance in Tyrosine Kinase Inhibitor-Naïve and Dasatinib Resistant BCR-ABL1+ Cell Lines
Oncotarget
Oncology
The T-Cell Response to Lipid Antigens of Mycobacterium Tuberculosis
Frontiers in Immunology
Allergy
Immunology
Ibrutinib: The First Bruton's Tyrosine Kinase Inhibitor
Prescriber
Pharmacology
Phase 1 Trial of Dasatinib Combined With Afatinib for Epidermal Growth Factor Receptor- (EGFR-) Mutated Lung Cancer With Acquired Tyrosine Kinase Inhibitor (TKI) Resistance
British Journal of Cancer
Cancer Research
Oncology
Overexpression of Syk Tyrosine Kinase in Peripheral T-Cell Lymphomas
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Identification of an Intracellular Metabolic Signature Impairing Beta Cell Function in the Rat Beta Cell Line INS-1E and Human Islets
Diabetologia
Internal Medicine
Endocrinology
Metabolism
Diabetes
Networked T Cell Death Following Macrophage Infection by Mycobacterium Tuberculosis
